Among the 129 subjects who provided CSF (Table 1B), there was a nearly 1:1 ratio in the number of PD subjects to the number of unaffected controls (UC) and in the number of LRRK2+ subjects to those without a LRRK2 mutation. The gene discussed is LRRK2; the disease is Parkinson disease.